L'Oréal

Shanghai – – September 28, 2026 -- MOYOM Biotech, a Chinese developer of regenerative aesthetic biomaterials, has secured a new financing round from the Cathay Consumer Co-Creation Fund, managed by Cathay Capital, to fund international expansion of its flagship CaHA-based implant brand Aphranel®.

Cathay Capital Fund Backed by L'Oréal Targets Beauty and Skin Science Innovation

The investment vehicle was jointly established by Cathay Capital, L'Oréal and the Shanghai Jing'an District Government. Cathay Capital's broader portfolio includes Moonshot AI (Kimi), autonomous driving firm Momenta, U.S. fintech Chime, digital asset platform Ledger, delivery platform Glovo and AI biotech company Owkin.

Delray Beach, Fla. – September 17, 2026 -- The global retail analytics market is projected to nearly double from $11.82 billion in 2026 to $23.21 billion by 2032, a compound annual growth rate of 11.9%, according to MarketsandMarkets. The market stood at $10.44 billion in 2025, with the six-year expansion driven by retailers deploying AI and machine learning across merchandising, supply chain, and customer engagement functions.